STOCK TITAN

Trigran group reports 4.2% MiMedx (MDXG) stake in amended Schedule 13G

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

MiMedx Group, Inc. has a new ownership update from Trigran-affiliated investors. An amended Schedule 13G shows Trigran Investments, Inc. and related individuals collectively reporting beneficial ownership of 6,163,384 shares of MiMedx common stock, representing 4.2% of the outstanding class as of the reported date.

The group reports no sole voting or dispositive power, with shared voting power over 5,688,192 shares and shared dispositive power over 6,163,384 shares. The filers state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MiMedx.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.


SCHEDULE 13G




Comment for Type of Reporting Person: The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.


SCHEDULE 13G




Comment for Type of Reporting Person: The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.


SCHEDULE 13G




Comment for Type of Reporting Person: The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.


SCHEDULE 13G




Comment for Type of Reporting Person: The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.


SCHEDULE 13G




Comment for Type of Reporting Person: The Reporting Person disclaims beneficial ownership of the shares reported in this Schedule 13G, except to the extent of its pecuniary interest.


SCHEDULE 13G



Trigran Investments, Inc.
Signature:/s/ Lawrence A. Oberman
Name/Title:Executive Vice President
Date:02/13/2026
Douglas T. Granat
Signature:/s/ Douglas Granat
Name/Title:Executive Officer of Trigran Investments, Inc.
Date:02/13/2026
Lawrence A. Oberman
Signature:/s/ Lawrence A. Oberman
Name/Title:Executive Vice President of Trigran Investments, Inc
Date:02/13/2026
Steven G. Simon
Signature:/s/ Steve G. Simon
Name/Title:Steve G. Simon
Date:02/13/2026
Bradley F. Simon
Signature:/s/ Bradley F. Simon
Name/Title:Bradley F. Simon
Date:02/13/2026
Steven R. Monieson
Signature:/s/ Steven R. Monieson
Name/Title:Steven R. Monieson
Date:02/13/2026
Exhibit Information

Exhibit 1: Agreement to Make a Joint Filing

FAQ

What ownership stake in MiMedx Group (MDXG) does Trigran report in this Schedule 13G/A?

Trigran Investments, Inc. and related individuals report beneficial ownership of 6,163,384 shares of MiMedx common stock, representing 4.2% of the outstanding class. This reflects their aggregated position as of the event date disclosed in the filing.

Who are the reporting persons in the MiMedx (MDXG) Schedule 13G/A amendment?

The filing lists Trigran Investments, Inc. plus individuals Douglas T. Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon, and Steven R. Monieson as reporting persons. They also file an Agreement to Make a Joint Filing as an exhibit.

How much voting and dispositive power do the Trigran filers report over MiMedx (MDXG) shares?

The filers report no sole voting or dispositive power, but shared voting power over 5,688,192 shares and shared dispositive power over 6,163,384 shares of MiMedx common stock, according to the cover-page ownership details.

Do the Trigran reporting persons seek control of MiMedx Group (MDXG)?

The certification states the MiMedx securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Why does the MiMedx (MDXG) Schedule 13G/A mention ownership of 5 percent or less?

Item 5 notes ownership of 5 percent or less of a class, consistent with the reported 4.2% beneficial ownership. This indicates the reporting group’s stake is below the 5% threshold that typically triggers initial Schedule 13D or 13G reporting.

What disclaimers do the Trigran filers make about MiMedx (MDXG) share ownership?

Each reporting person notes they disclaim beneficial ownership of the reported shares except to the extent of any pecuniary interest. This is a standard clarification about economic versus formal beneficial ownership in Schedule 13G filings.
Mimedx Group Inc

NASDAQ:MDXG

MDXG Rankings

MDXG Latest News

MDXG Latest SEC Filings

MDXG Stock Data

758.28M
145.45M
1.7%
71.51%
3.36%
Biotechnology
Surgical & Medical Instruments & Apparatus
Link
United States
MARIETTA